Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines.
P2860
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@ast
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@en
type
label
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@ast
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@en
prefLabel
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@ast
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@en
P2093
P2860
P1476
Augmentation of autologous T c ...... l-like receptor (TLR) agonists
@en
P2093
Edward D Ball
Hongying Li
Jiehua Zhou
Karen Messer
RuiKun Zhong
Thomas A Lane
P2860
P2888
P304
P356
10.1007/S00262-015-1680-X
P577
2015-03-21T00:00:00Z